Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mRNA induced expression of human angiotensin-converting enzyme 2 in mice for the study of the adaptive immune response to severe acute respiratory syndrome coronavirus 2
Mariah Hassert, Elizabeth Geerling, E. Taylor Stone, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 12, pp. e1009163-e1009163
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19
Alba Grifoni, John Sidney, Randi Vita, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1076-1092
Open Access | Times Cited: 298
Animal Models for COVID-19: Hamsters, Mouse, Ferret, Mink, Tree Shrew, and Non-human Primates
Shuyu Shou, Menghui Liu, Yang Yang, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 108
Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung
Ting-Hsuan Wu, Kyle J. Travaglini, Arjun Rustagi, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 6
Open Access | Times Cited: 18
SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses
Joshua M. Carmen, Shikha Shrivastava, Zhongyan Lu, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 67
Cross-protective immunity following coronavirus vaccination and coronavirus infection
Tanushree Dangi, Nicole Palacio, Sarah Sanchez, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 24
Open Access | Times Cited: 52
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization
Amy B. Karger, James D. Brien, Jayne M. Christen, et al.
mSphere (2022) Vol. 7, Iss. 4
Open Access | Times Cited: 23
mRNA-LNP vaccine-induced CD8+ T cells protect mice from lethal SARS-CoV-2 infection in the absence of specific antibodies
Brian Montoya, Carolina R. Melo‐Silva, Lingjuan Tang, et al.
Molecular Therapy (2024) Vol. 32, Iss. 6, pp. 1790-1804
Open Access | Times Cited: 5
Modulation of ACE-2 mRNA by inflammatory cytokines in human thyroid cells: a pilot study
Francesca Coperchini, Gianluca Ricci, Laura Croce, et al.
Endocrine (2021) Vol. 74, Iss. 3, pp. 638-645
Open Access | Times Cited: 27
Metabolic syndrome enhances SARS-CoV-2 disease severity and reduces mRNA vaccine efficacy in a mouse model
Elizabeth Geerling, E. Taylor Stone, Danielle Carpenter, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination
Yeonsu Kim, Xiaoyan Zheng, Kathrin Eschke, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 2, pp. 234-244
Open Access | Times Cited: 15
In Silico Evaluation of Different Flavonoids from Medicinal Plants for Their Potency against SARS-CoV-2
H. R. Abd El-Mageed, Doaa A. Abdelrheem, Md. Oliullah Rafi, et al.
Biologics (2021) Vol. 1, Iss. 3, pp. 416-434
Open Access | Times Cited: 19
Immuno-Colorimetric Neutralization Test: A Surrogate for Widely Used Plaque Reduction Neutralization Tests in Public Health Virology
Sunil R. Vaidya
Viruses (2023) Vol. 15, Iss. 4, pp. 939-939
Open Access | Times Cited: 6
Post-acute immunological and behavioral sequelae in mice after Omicron infection
Tongcui Ma, Rahul K. Suryawanshi, Stephanie R. Miller, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
Activated interstitial macrophages are a predominant target of viral takeover and focus of inflammation in COVID-19 initiation in human lung
Ting-Hsuan Wu, Kyle J. Travaglini, Arjun Rustagi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Closed Access | Times Cited: 10
T cell responses to SARS-CoV-2 in humans and animals
Sameer-ul-Salam Mattoo, Jinjong Myoung
The Journal of Microbiology (2022) Vol. 60, Iss. 3, pp. 276-289
Open Access | Times Cited: 9
Metal coordinating inhibitors of Rift Valley fever virus replication
Elizabeth Geerling, Valerie Murphy, Chikha Maria, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0274266-e0274266
Open Access | Times Cited: 9
A spike-ferritin nanoparticle vaccine induces robust innate immune activity and drives polyfunctional SARS-CoV-2-specific T cells
Joshua M. Carmen, Shikha Shrivastava, Zhongyan Lu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 9
SARS-CoV-2 acquisition and immune pathogenesis among school-aged learners in four diverse schools
Dan M. Cooper, Michael Z. Zulu, Allen Jankeel, et al.
Pediatric Research (2021) Vol. 90, Iss. 5, pp. 1073-1080
Open Access | Times Cited: 8
Allotypic variation in antigen processing controls antigenic peptide generation from SARS-CoV-2 S1 spike glycoprotein
George Stamatakis, Martina Samiotaki, Ioannis Temponeras, et al.
Journal of Biological Chemistry (2021) Vol. 297, Iss. 5, pp. 101329-101329
Open Access | Times Cited: 7
The role of vaccination route with an adenovirus-vectored vaccine in protection, viral control, and transmission in the SARS-CoV-2/K18-hACE2 mouse infection model
Alexandria Dickson, Elizabeth Geerling, E. Taylor Stone, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Preclinical Evaluation of a Cross-Protective ß-SARS-CoV-2 Virus-Like Particle Vaccine Adjuvanted with MF59
Linda Earnest, Daniel Fernandez‐Ruiz, Melissa A. Edeling, et al.
(2024)
Open Access
Preclinical evaluation of a cross-protective ß-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59
Joseph Torresi, Linda Earnest, Daniel Fernandez‐Ruiz, et al.
Research Square (Research Square) (2024)
Open Access
SARS-CoV-2 Acquisition and Immune Pathogenesis Among School-Aged Learners in Four Diverse Schools
Dan M. Cooper, Michael Z. Zulu, Allen Jankeel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3
Metal Coordinating Inhibitors of Rift Valley Fever virus Replication
Elizabeth Geerling, Valerie Murphy, E. Taylor Stone, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization
Amy B. Karger, James D. Brien, Jayne M. Christen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top